Skip to content

Study · Not a test of the peptide alone · 2019

1 result

[TREATMENT OF SECRETORY OTITIS MEDIA IN CHILDREN, DEPENDING ON THE STAGE OF THE PROCESS AND ON THE BACKGROUND OF THE PATHOLOGICAL CONDITIONS].

Kulikova E, Golovko N, Chumakova A, Panchenko T

Georgian medical news1 Nov 2019

PMID31889704 (opens in a new tab)PepBankPUB-31889704

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In children with secretory otitis media, thymalin with endaural phonophoresis followed by Broncho-Vaxom produced the fewest relapses among treatment groups.

    In plain wordsIn children with secretory otitis media, the thymalin, phonophoresis and Broncho-Vaxom regimen produced fewer relapses than other treatment groups.

    Peptide
    Thymalin
    Outcome
    DecreaseSecretory otitis media relapses
    Study

    n: not reported in source

    Comparator
    Other treated groups of children with secretory otitis media
    Outcome group
    Overall treatment effect · Whole body

    Source sentences

    Summary
    It was these children who had the least number of relapses SOM of against the background of the best indicators of immunity.
    1 context sentence
    Summary · context
    Therefore, the examined children, divided into 3 groups, received various immunomodulating agents: thymalin and Broncho-Vaxom (bacterial lysate), and in some cases we combined topical administration of thymalin with endaural phonophoresis followed by treatment with Broncho-Vaxom.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.